Idorsia Pharmaceuticals Ltd.

This study follows adults with Fabry disease who previously took lucerastat in an earlier trial. Researchers want to understand the long-term safety and side effects of continuing this oral medication. The study will monitor participants for up to 8 years or until the drug become…